BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 19394664)

  • 21. TB presenting as community-acquired pneumonia in a setting of high TB incidence and high HIV prevalence.
    Nyamande K; Lalloo UG; John M
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1308-13. PubMed ID: 18034951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress towards tuberculosis elimination in Cuba.
    González E; Armas L; Llanes MJ
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):405-11. PubMed ID: 17394686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TB in health care workers in KwaZulu-Natal, South Africa.
    Naidoo S; Jinabhai CC
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):676-82. PubMed ID: 16776456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TB treatment: as simple as DOT?
    Pope DS; Chaisson RE
    Int J Tuberc Lung Dis; 2003 Jul; 7(7):611-5. PubMed ID: 12870680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.
    Lester R; Hamilton R; Charalambous S; Dwadwa T; Chandler C; Churchyard GJ; Grant AD
    AIDS; 2010 Nov; 24 Suppl 5():S45-8. PubMed ID: 21079427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of directly observed therapy for tuberculosis in Yokohama City, Japan.
    Tsuchida K; Koyanagi H
    Int J Tuberc Lung Dis; 2003 Aug; 7(8):730-4. PubMed ID: 12921148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model.
    Cavalcante SC; Soares EC; Pacheco AG; Chaisson RE; Durovni B;
    Int J Tuberc Lung Dis; 2007 May; 11(5):544-9. PubMed ID: 17439679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Directly observed treatment for tuberculosis in pharmacies compared with self-administered therapy in Spain.
    Juan G; Lloret T; Perez C; Lopez P; Navarro R; Ramón M; Cortijo J; Morcillo EJ
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):215-21. PubMed ID: 16499264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect on tuberculosis outcomes of educational outreach to South African clinics during two randomised trials.
    Bachmann MO; Fairall LR; Lombard C; Timmerman V; van der Merwe S; Bateman ED; Zwarenstein M
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):311-7. PubMed ID: 20132622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand.
    Kapella BK; Anuwatnonthakate A; Komsakorn S; Moolphate S; Charusuntonsri P; Limsomboon P; Wattanaamornkiat W; Nateniyom S; Varma JK
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):232-7. PubMed ID: 19146753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid DOTS expansion in India.
    Khatri GR; Frieden TR
    Bull World Health Organ; 2002; 80(6):457-63. PubMed ID: 12132002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis: current trends in diagnosis and treatment.
    Bello AK; Njoku CH
    Niger J Clin Pract; 2005 Dec; 8(2):118-24. PubMed ID: 16477867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Southern Africa is moving swiftly to combat the threat of XDR-TB.
    Wise J
    Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824
    [No Abstract]   [Full Text] [Related]  

  • 34. Concurrent ART/TB treatment finally proven to be beneficial.
    Ryan CT
    AIDS Clin Care; 2008 Nov; 20(11):89. PubMed ID: 19170252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indigenous NGO involvement in TB treatment programmes in high-burden settings: experiences from the Northern Cape province, South Africa.
    Kironde S; Neil S
    Int J Tuberc Lung Dis; 2004 Apr; 8(4):504-8. PubMed ID: 15141746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model.
    Atun RA; Lebcir R; Drobniewski F; Coker RJ
    Int J STD AIDS; 2005 Aug; 16(8):560-70. PubMed ID: 16105192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development and perspectives of community DOTS].
    Narita T; Kobayashi N
    Kekkaku; 2009 Apr; 84(4):187-201. PubMed ID: 19425394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tuberculosis in Poland, Europe, and world. Part II--mortality, drug resistance and HIV infection].
    Zielonka TM
    Pol Merkur Lekarski; 2006 Sep; 21(123):253-61. PubMed ID: 17163187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scientific basis of directly observed treatment, short-course (DOTS).
    Sharma SK; Mohan A
    J Indian Med Assoc; 2003 Mar; 101(3):157-8, 166. PubMed ID: 14603962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An exploration of the concept of directly observed treatment (DOT) for tuberculosis patients: from a uniform to a customised approach.
    Macq JC; Theobald S; Dick J; Dembele M
    Int J Tuberc Lung Dis; 2003 Feb; 7(2):103-9. PubMed ID: 12588009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.